Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CircumSPECT Diagnostic and Services is a specialized nuclear medicine and molecular imaging center based in Mumbai, India. The facility provides advanced diagnostic imaging services, including PET-CT and SPECT-CT, focusing on oncology, cardiology, and nephrology. Key offerings include high-precision scans such as PSMA PET for prostate cancer and DOTA PET for neuroendocrine tumors, alongside myocardial perfusion imaging for heart disease. Beyond diagnostics, the center provides radionuclide therapies, including Lutetium-177 (Lu-177) treatments for advanced cancers. As a dedicated molecular imaging hub, CircumSPECT supports precision medicine through state-of-the-art technology and expert clinical interpretation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CircumSPECT Diagnostic and Services.